HBAN vs TRDA · P/E 13, rev $1.56B vs P/E 12, rev $1.8M
Huntington Bancshares Incorporated (HBAN) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Huntington Bancshares Incorporated (HBAN) is a banks - regional company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported HBAN revenue for 2025-12-31 was $1.56B. Net income was $2.21B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
Latest reported TRDA revenue for 2026-06-30 was $1.8M. Net income was -$82.5M. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
HBAN currently screens at market cap $25.55B and trailing P/E 13.5. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the HBAN and TRDA stock pages for the full models.
Not investment advice.